NCT06819865

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

EkoSonic Endovascular System in China RWS(ANTEATER)

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.

Detailed description

This is a multi-center, single arm, prospective, observational, real-world study.To collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care. Up to 30 patients will be enrolled in this study and up to 30 patients will be enrolled in this study to observation safety and efficacy.

Conditions

• Acute Pulmonary Embolism

Interventions

Type	Name	Description
DEVICE	EkoSonicTM Endovascular System	EkoSonicTM Endovascular System and its upgraded versions if applicable The EkoSonicTM Endovascular System is a non-implanted system comprising a sterile, single-use EkoSonic Endovascular Device (Infusion Catheter and Ultrasonic Core) and reusable EKOSTM Control System 4.0(Control Unit, Connector Interface Cable and power cord).

Timeline

• Start date: 2026-03-30
• Primary completion: 2027-03-30
• Completion: 2028-07-30
• First posted: 2025-02-11
• Last updated: 2026-03-31

Regulatory

• FDA-regulated device study